Company name
INFORMUTA
Stage Invested
Series B 2024
Company Description:
Informuta’s mission is to revolutionize infectious disease detection and enable precision medicine for infections.
We do this through artificial intelligence/machine learning (AI/ML)-powered analytics of DNA, namely next-generation sequencing (NGS), data. Our novel, proprietary technology allows us to leverage DNA sequencing to predict if bacteria will respond to different antibiotics or develop resistance to them over time. Our vision is to address the global health crisis of antibiotic resistance and save lives by learning to better use and therefore conserve our current market-approved antibiotics.
Website:
INFORMUTA in the news:
Check back soon!